References
- CrawfordEDEpidemiology of prostate cancerUrology2003626 Suppl 131214706503
- ScherHIIsaacsJTZelefskyMJProstate cancerAbeloffMDArmitageJOLichterASClinical Oncology2nd edNew York, NYChurchill Livingstone2000
- BechisSKCarrollPRCooperbergMRImpact of age at diagnosis on prostate cancer treatment and survivalJ Clin Oncol20112923524121135285
- ChodakGWThistedRAGerberGSResults of conservative management of clinically localized prostate cancerN Engl J Med1994332422488272085
- TetuBRoJYAyalaAGSmall cell carcinoma of the prostate: Part 1 – A clinicopathologic study of 20 casesCancer198759180318093030528
- RoJYTêtuBAyalaAGOrdóñezNGSmall cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 casesCancer1987599779822434204
- PearseAGTakorTEmbryology of the diffuse neuroendocrine system and its relationship to the common peptidesFed Proc1979382288229437125
- AmatoRJLogothetisCJHallinanRChemotherapy for small cell carcinoma of prostatic originJ Urol19921479359371311396
- OesterlingJEHauzeurCGFarrowGMSmall cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patientsJ Urol19921478048071311395
- WangWEpsteinJISmall cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 casesAm J Surg Pathol200832657118162772
- HelpapBKöllermannJOehlerUNeuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectivesUrol Int19996213313810529661
- BonkhoffHRembergerKDifferentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell modelProstate199628981068604398
- YancikRCancer burden in the aged: an epidemiologic and demographic overviewCancer199780127312839317180
- WalterLCCovinskyKECancer screening in elderly patients. A framework for individualized decision makingJAMA20012852750275611386931
- Surveillance, Epidemiology, and End Results (SEER) ProgramPublic-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2002, based on the November 2006 submission Available from: http://www.seer.cancer.gov/about/expansion.htmlAccessed Nov 29, 2008
- GleasonDFClassification of prostatic carcinomasCancer Chemother Rep1966501251285948714
- KaplanELMeierPNonparametric estimation from incomplete observationsJ Am Stat Assoc195853457481
- CoxDRRegression models and life-tablesJ Royal Stat Soc B197234187220
- Turbat-HerreraEAHerreraGAGoreINeuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy studyArch Pathol Lab Med1988112110011052460064
- YashiMIshikawaSOchiMSmall cell/neuroendocrine carcinoma may be a more common phenotype in advanced prostate cancerUrol Int20026916616812187054
- NadigSNDeiblerAREl SalamonyTMSmall cell carcinoma of the prostate: an underrecognized entityCan J Urol200181207121011268310
- MiyoshiYUemuraHKitamiKNeuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapyBJU Int20018898298311851626
- PalmgrenJSKaravadiaSSWakefieldMRUnusual and underappreciated: small cell carcinoma of the prostateSemin Oncol200734222917270662
- YashiMIshikawaSOchiMTokueASmall cell/neuroendocrine carcinoma may be a more common phenotype in advanced prostate cancerUrol Int20026916616812187054
- AustinJPConveryKAge race interaction in prostatic adenocarcinoma treated with external beam irradiationAm J Clin Oncol1993161401458452106
- GronbergHDamberJEJonssonHLennerPPatient age as a prognostic factor in prostate cancerJ Urol19941528928958051746
- HeroldDMHanlonALMovsasBHanksGEAge-related prostate cancer metastasesUrology1998519859909609637
- ObekCLaiSSadekSCivantosFSolowayMSAge as a prognostic factor for disease recurrence after radical prostatectomyUrology19995453353810475367
- FreedlandSJPrestiJCKaneCJDo younger men have better biochemical outcomes after radical prostatectomy?Urology20046351852215028449
- ScosyrevEMessingEMMohileSGolijaninDWuGProstate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortalityCancer20121183062307022006014
- SchröderFHHugossonJRoobolMJERSPC InvestigatorsProstate-cancer mortality at 11 years of follow-upN Engl J Med201236698199022417251
- AndrioleGLCrawfordEDGrubbRL3rdPLCO Project TeamProstate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-upJ Natl Cancer Inst201210412513222228146
- MettlinCJMurphyGPCunninghamMPMenckHRThe National Cancer Data Base report on race, age, and region variations in prostate cancer treatmentCancer199780126112669317177
- BechisSKCarrollPRCooperbergMRImpact of age at diagnosis on prostate cancer treatment and survivalJ Clin Oncol20112923524121135285
- DeorahSRaoMBRamanRGaitondeKDonovanJFSurvival of patients with small cell carcinoma of the prostate during 1973–2003: a population-based studyBJU Int201210982483021883857
- RaoAVValkPJMetzelerKHAge-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemiaJ Clin Oncol2009275580558619858393
- MostertzWStevensonMAcharyaCAge- and sex-specific genomic profiles in non-small cell lung cancerJAMA201030353554320145230